Liberation Behavioral Health (also known as Liberation Way), a Yardley, PA-based, state licensed and Joint Commission accredited drug and alcohol addiction treatment facility, received a growth equity investment of undisclosed amount.
Fulcrum Equity Partners, a Southeast firm that manages over $350m in capital, acquired a majority interest in the company with participation from Vocap Investment Partners.
Led by newly hired CEO Andrew “Drew” Rothermel, J.D, MBA, Liberation Way is a state licensed and Joint Commission accredited drug and alcohol addiction treatment facility, which utilizes a holistic model of care that is evidence-based and rooted in modern science, allowing the patient the ability to grow during treatment.
The company helps people addicted to opiates through a path to recovery program that uses a hybrid model formerly known as Partial Hospitalization Program/Intensive Outpatient Program (PHP/IOP).
Liberation Way will use its additional capital to bring new treatment programs to underserved areas of New Jersey, New York and Pennsylvania.